Home › Plexiform Neurofibroma › Indiana › Indianapolis
Plexiform Neurofibroma clinical trials in Indianapolis, IN
3 studies for Plexiform Neurofibroma are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
RecruitingPhase 1
- Riley Hospital for Children/Indiana University, Indianapolis
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
RecruitingPhase 2
- Indiana University, Indianapolis
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RecruitingPhase 2
- Riley Hospital for Children/Indiana University, Indianapolis
Plexiform Neurofibroma trials in other cities
- Washington, DC7 studies
- Philadelphia, PA4 studies
- Birmingham, AL4 studies
- Los Angeles, CA3 studies
- Dallas, TX3 studies
- Cincinnati, OH3 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Breast Cancer20 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Lung Cancer16 studies
- Cardiovascular Disease16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.